Supreme Court Issues Directions to Speed Up MACT Claims Amid Six-Year Average Pendency || Supreme Court: Sex Selection Practices Continues Due to Preference For Male Children || Supreme Court: Injury From a Fallen Tree is Not a Motor Accident for MACT Claims || Madras HC: Recent Tamil Nadu Elections Reflect Voting Beyond Caste and Community Considerations || Supreme Court: Children Should Not Undergo Psychological Tests in Custody Cases Unless Necessary || Jharkhand HC: Lokayukta Cannot Delegate Core Adjudicatory Powers Even in Case Against Brother || Ker HC: Complainant Can Invoke Presumptions After Proving Transaction, Cheque Execution Convincingly || Supreme Court Cancels SARFAESI Auction Sale After 16 Years Due to a 5-Day Payment Delay || Jhar HC Orders 2-Month Probe Deadline, DGP Monitoring to Overhaul Sexual Violence Response in State || Delhi HC: Social Media Cannot Undermine Judiciary; Intermediaries Must Act Without Court Orders

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :